Competitive Information Sample Clauses
The Competitive Information clause defines how information related to competitors or competitive activities is handled within the context of an agreement. Typically, this clause restricts the parties from sharing, using, or soliciting confidential information that pertains to competitors, such as pricing strategies, product development plans, or marketing tactics. By establishing clear boundaries on the use and disclosure of competitive information, the clause helps prevent conflicts of interest and protects sensitive business data, thereby reducing the risk of unfair competition or legal disputes.
POPULAR SAMPLE Copied 1 times
Competitive Information. Each of the parties acknowledges and understands that the other party may now market or have under development products or services which are competitive with products or services now offered or which may be offered by the other party, and, except as expressly set forth in this Agreement, the parties’ communications hereunder will not serve to impair the right of either party to develop, make, use, procure or market products or services now or in the future which may be competitive with those offered by the other party, nor require either party to disclose any planning or other information to the other party.
Competitive Information. Provide any/all information on new products entering the local markets.
Competitive Information. A. Potential competitors
1. There are no direct competitors known to be developing a see-thru BIPV product with the characteristics specific to Licensee’s proposed application of the Licensed Patents and Licensed Know-How to its SolarWindow™ technology
2. There are numerous solar/photovoltaic/BIPV companies, which may develop products and/or technologies capable of competing against Licensee:
a) Konarka Technologies, Inc.
b) Nanosolar, Inc.
c) General Electric d) BP Solar e) Energy Conversion Devices / United Solar Ovonic
B. Potential competitive devices/compositions
1. Solar blinds
2. Ultra-thin films
3. Embedded solar ‘strips’ inside glass windows
C. Anticipated date of product launch Initials /s/ VLM MP1735585.1 Initials /s/ VLM MP1735585.1
Competitive Information. Financial Provisions and Commercially Sensitive Terms. 16 Competitive Information – Commercially Sensitive Terms. 17 Competitive Information – Financial Provisions and Commercially Sensitive Terms.
Competitive Information. Discovery Information. 68 Competitive Information – Financial Provisions and Discovery Information. 69 Competitive Information – Financial Provisions. 70 Competitive Information – Financial Provisions, Discovery Information and Commercially Sensitive Terms. 71 Competitive Information – Commercially Sensitive Terms.
Competitive Information. Commercially Sensitive Terms.
(c) Zymeworks may, itself or through its Affiliates and licensees, use such right of reference to BeiGene’s Regulatory Submissions and Regulatory Approvals solely for the purpose of seeking, obtaining and maintaining Regulatory Approval of Licensed Products outside the Territory or, to the extent permitted pursuant to this Agreement, in the Territory. Without limiting the foregoing, Zymeworks may, itself or through its Affiliates and licensees, use such right of reference to BeiGene’s regulatory submissions and Regulatory Approvals for Tisle Product (a) to support Regulatory Submissions for the Tisle Combination Studies outside of the Territory and, to the extent permitted, in the Territory and (b) for the purpose of seeking, obtaining and maintaining Regulatory Approval of Licensed Products for use in combination with Tisle Product outside the Territory.
(d) The Party requesting such right of reference shall bear the reasonable costs and expenses of the other Party associated with providing the right of reference pursuant to this Section 6.3. Each Party will take such actions as may be reasonably requested by the other Party to give effect to the intent of this Section 6.3 and to give the other Party the benefit of the rights of reference to the granting Party’s regulatory submissions in the other Party’s territory as provided herein.”
10. Section 7.3
Competitive Information. The Company will use its good faith efforts to prevent its disclosure, directly or indirectly, to any Investor of competitively sensitive material information about a competitor of such Investor, including pricing and margin information and terms of sale.
Competitive Information. Exclusivity Information. 15 Competitive Information – Exclusivity Information. 16 Competitive Information – Exclusivity Information. 17 Competitive Information – Exclusivity Information. 18 Competitive Information – Exclusivity Information. 19 Competitive Information – Technical Information. 20 Competitive Information – Exclusivity Information. 21 Competitive Information – Exclusivity Information. provision of this Amendment may be amended or modified other than by a written document signed by authorized representatives of each Party.
Competitive Information. The Parties shall consult with outside antitrust counsel before any competitively sensitive information (including price information, strategic and marketing plans and customer-specific information) is provided to the Parent Group pursuant to Section 10.1.
Competitive Information. Exclusivity Information. 33 Competitive Information – Commercially Sensitive Terms. Territory and the Development and manufacture of Licensed Products pursuant to the Global Development Plan outside of the Territory and (ii) provide a forum for Zymeworks to provide updates with respect to the Commercialization of Licensed Products outside of the Territory to the extent necessary and useful for BeiGene in its Commercialization of Licensed Products in the Field in the Territory. The JSC will be composed of an equal number of representatives from each Party and a minimum of three (3) representatives of each Party, with (i) at least two (2) senior-level representatives from BeiGene who are fluent in English, (ii) at least two (2) representatives of each Party that have direct knowledge and expertise in the development, manufacture and commercialization of biopharmaceutical products provided that with respect to BeiGene, at least one of such representatives will be fluent in English and (iii) at least one representative of each Party holding the position of vice president or above in such Party. Each representative to the JSC shall be an employee of the applicable Party, unless otherwise agreed by both Parties.34